Buy Ranbaxy for target of Rs 458-465: Arihant

Arihant Capital Markets has advised traders to buy Ranbaxy Laboratories for target of Rs 458-465.

By ET Bureau | Jun 22, 2010, 11.46 AM IST

MUMBAI: Arihant Capital Markets has advised traders to buy Ranbaxy Laboratories for target of Rs 458-465.

"Buy Ranbaxy Laboratories with stoploss of Rs 438 for target of Rs 458-465," the report said.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!

Ranbaxy-Daiichi case: SC asks lenders to place loan records of Malvinder, Shivinder2021-02-18T15:12:31Z
Ranbaxy case: Malvinder Singh provides proof of financial deals with Radha Soami Satsang head2020-08-28T04:48:21Z
Daiichi-Ranbaxy arbitration case: Singh brothers hearing in Singapore Supreme Court starts today2020-02-24T02:25:33Z

Ranbaxy |capital |Arihant

50 TIMESPOINTS

Related Companies

Arihant

Buy Tata Steel for target of Rs 531: APTART

Buy Ranbaxy for target of Rs 458-465: Arihant

Arihant Capital Markets has advised traders to buy Ranbaxy Laboratories for target of Rs 458-465.

Related Articles

READ MORE:

Related Companies

More from our Partners

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News

Download ET APP

Follow us on

become a member